Indian Government Clears Foreign Direct Investment Proposals of Lupin, Alkem Lab
The Foreign Investment Promotion Board, chaired by Economic Affairs Secretary Shaktikanta Das, in its meeting considered 14 FDI proposals for approval.
The Foreign Investment Promotion Board, chaired by Economic Affairs Secretary Shaktikanta Das, in its meeting considered 14 FDI proposals for approval.
‘Lupin has launched calcium acetate capsules having received final approval from the US health regulator.’
Tweet it Now
The Mumbai-based firm’s product is the generic version of Fresenius Medical Care North America’s PhosLo Gelcaps.The drug is indicated for the control of hyperphosphatemia in end stage renal failure.
As per IMS sales data, PhosLo Gelcaps had annual US sales of $54.5 million.
USFDA Approved Lupin's Anti-Cholesterol Drug may Not Fatten Up Firm Financials
Lupin Ltd's anti-cholesterol drug is highly competitive and hence unlikely to contribute significantly to the company, though its getting approval is positive.
Lupin Ltd's anti-cholesterol drug is highly competitive and hence unlikely to contribute significantly to the company, though its getting approval is positive.
Source-PTI
Pivotal Expansion: Lupin Pharmaceuticals Acquires US-Based Gavis for $880 Million
In a pivotal move to expand their global presence, an Indian Pharmaceutical company- Lupin Pharmaceuticals, acquired Gavis, a US- based privately- held company.
In a pivotal move to expand their global presence, an Indian Pharmaceutical company- Lupin Pharmaceuticals, acquired Gavis, a US- based privately- held company.
FDA Gives Approval to Lupin to Market Generic Cipro in US
The USFDA has given approval for Mumbai-based pharmaceutical company Lupin to market the generic versions of Bayer’s Cipro.
The USFDA has given approval for Mumbai-based pharmaceutical company Lupin to market the generic versions of Bayer’s Cipro.
